56
Participants
Start Date
September 30, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
March 31, 2011
American ginseng extract HT-1001
Ginseng HT-1001 was dosed at 100 mg orally per day initially, increased after one week to 200 mg per day, then further increased the next week to 400 mg per day as tolerated. Subjects were then maintained on 400 mg per day or the maximum tolerated dose for the remainder of the 6 week treatment period.
placebo
Placebo capsules were identical to the study drug and were dose escalated to match the study drug. Subjects were maintained on placebo capsules for the remainder of the 6 week treatment period.
Oregon Health & Science University, Portland
National Multiple Sclerosis Society
OTHER
Oregon Health and Science University
OTHER